Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

515
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
515
Cancer Therapies02:49

Cancer Therapies

7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Cancer Vaccines01:30

Cancer Vaccines

355
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
355
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

892
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
892
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Radiation Oncology-Biology Integration Network: Bridging the Gap between Biological Research and Clinical Practice.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Serotonin Modulates Lineage Plasticity in Neuroendocrine Prostate Cancer via Epigenetic Reprogramming.

Cancer discovery·2025
Same author

Publisher Correction: Radiation-induced amphiregulin drives tumour metastasis.

Nature·2025
Same author

Radiotherapy induces YTHDF2 in dendritic cells impairing cross-presentation and T cell function.

The Journal of experimental medicine·2025
Same author

Amphiregulin as a Mediator of Radiation-Induced Systemic Effects in Metastatic Cancer: Balancing Local Control with Distant Progression.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same author

NNMT inhibition in cancer-associated fibroblasts restores antitumour immunity.

Nature·2025

相关实验视频

Updated: Jun 25, 2025

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine
05:39

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine

Published on: April 5, 2024

812

辐射疗法和免疫学

Liangliang Wang1,2, Connor Lynch1,2, Sean P Pitroda1,2

  • 1Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL, USA.

The Journal of experimental medicine
|May 21, 2024
PubMed
概括

放射治疗通过调节免疫系统,影响癌症治疗. 了解这种免疫激活和抑制的平衡是提高放射治疗疗效的关键.

更多相关视频

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:01

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

325
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.1K

相关实验视频

Last Updated: Jun 25, 2025

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine
05:39

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine

Published on: April 5, 2024

812
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:01

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

325
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.1K

科学领域:

  • 在瘤学瘤学.
  • 免疫学 免疫学 免疫学
  • 放射治疗研究 放射治疗研究

背景情况:

  • 放射治疗是癌症治疗的基石,历史上专注于DNA损伤.
  • 最近的研究强调了免疫系统在放射治疗的抗瘤作用中的重要作用.
  • 放射治疗影响瘤微环境中的前瘤和抗瘤免疫反应.

研究的目的:

  • 审查免疫系统在放射治疗诱导的抗瘤效应中的双重作用.
  • 探索放射治疗如何重编程瘤微环境以调节免疫力.
  • 要总结结合照射疗法与免疫检查点抑制剂的临床试验.

主要方法:

  • 对放射治疗及其免疫调节作用的当前文献的综述.
  • 分析放射治疗激活或抑制抗瘤免疫力的机制.
  • 汇编和审查临床试验数据的放射治疗与PD-1/PD-L1和CTLA-4阻塞结合.

主要成果:

  • 放射治疗通过DNA/RNA传感途径激活先天性和适应性免疫.
  • 放射治疗还可以通过招募调节细胞来抑制抗瘤免疫力.
  • 亲和抗瘤免疫之间的相互作用是由细胞因子和化学因子介导的.
  • 微生物群的组成可以影响放射治疗的结果.
  • 放射治疗与免疫检查点抑制剂 (PD-1/PD-L1,CTLA-4) 的结合正在进行广泛的临床研究.

结论:

  • 放射治疗对抗瘤免疫反应产生复杂的影响,包括激活和抑制.
  • 调节免疫微环境和考虑微生物群等因素对于优化放射治疗至关重要.
  • 通过放射治疗研究免疫检查点阻塞的临床试验显示,增强治疗疗效有望提高.